Back to Treatments

Treatment

Combined Oral Contraceptives (Drospirenone/Ethinyl Estradiol)

1
Conditions
8
Trials
8,000
Participants
60%
Average Safety

Condition Evidence

Premenstrual Syndrome

8 trials · 8,000 participants

70% effectiveness · 60% safety
Combined Oral Contraceptives (Drospirenone/Ethinyl Estradiol) | DFDA